National Bank of Canada
GH icon

National Bank of Canada’s Guardant Health GH Stock Holding History

National Bank of Canada’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,106
Closed -$623K – 3054
2025
Q4 		$623K Buy
+6,106
New +$546K ﹤0.01% 1296
2025
Q3 		– Sell
-741
Closed -$38.5K – 2994
2025
Q2 		$38.5K Buy
+741
New +$33.1K ﹤0.01% 2020
2024
Q3 		– Sell
-2,000
Closed -$56.5K – 2870
2024
Q2 		$56.5K Hold
2,000
– – ﹤0.01% 1651
2024
Q1 		$44.7K Buy
+2,000
New +$42.9K ﹤0.01% 1792
2022
Q2 		– Sell
-321
Closed -$21K – 2855
2022
Q1 		$21K Hold
321
– – ﹤0.01% 2164
2021
Q4 		$32K Buy
+321
New +$33.2K ﹤0.01% 2022

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

National Bank of Canada's GH Position: Q1 2026 in Review

National Bank of Canada sold out of Guardant Health (GH) in Q1 2026, closing a stake of 6,106 shares — an estimated $623K sold.

National Bank of Canada first reported a position in GH in Q4 2021 and held it in 6 quarters. The position peaked at $623K in Q4 2025. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • National Bank of Canada reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • National Bank of Canada sold 6,106 Guardant Health shares in Q1 2026, an estimated $623K.
  • National Bank of Canada first reported a position in Guardant Health in Q4 2021 and held it in 6 quarters.
  • National Bank of Canada's Guardant Health position peaked at $623K in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.